EyePoint Pharmaceuticals (EYPT)
(Real Time Quote from BATS)
$8.61 USD
-0.14 (-1.60%)
Updated Aug 12, 2024 02:50 PM ET
3-Hold of 5 3
F Value A Growth F Momentum D VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 30% (75 out of 250)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.35 | 9.99 |
Current Quarter Estimate | -0.57 | 7.43 | 61.00 |
Year Ago Quarter Estimate | -0.33 | 0.12 | 54.84 |
Next Quarter Estimate | -0.61 | 7.81 | 63.00 |
Next Year Estimate | -3.07 | 37.76 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -25.82 | 16.80 | 15.67 |
Next Year | -34.06 | 9.90 | 11.34 |
Last 5 Years | NA | 0.70 | 8.10 |
Next 5 Years | NA | 21.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 2.00 | 2.03 |
Price/Cash Flow (MRFY) | NA | 16.15 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -172.30% | -22.37% |
Return on Equity (TTM) | -43.24% | -31.10% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.